Here, thanks to ePA standardization, the patient starts therapy the same day or next, greatly improving continuity of care
To understand the power of this peptide, we have to look beyond the scale
As efficacy benchmarks rise, the real differentiator may not be who builds the most complex molecule but who can execute across that complexity (trial design, patient stratification, safety signaling, real-world validation)
Its antioxidant properties may help reduce oxidative stress, which plays a significant role in the progression of chronic kidney disease (CKD)
According to reports, representatives of Novo Nordisk (Ozempic and Wegovy) and Eli Lilly (Mounjaro and Zepbound) said they do not endorse or encourage misuse of their products
And the common denominator in all of this